Browse the evidence

Bariatric weight loss surgery is significantly more effective than pharmacotherapy and lifestyle modifications for long-term weight loss and improvement of comorbid conditions in eligible patients, yet remains severely underutilized.

If you have severe obesity (BMI ≥ 40, or ≥ 35 with health issues, or ≥ 30 with diabetes) and lifestyle changes haven't worked, bariatric surgery is the most effective long-term solution, far surpassing drugs and diet alone. It improves diabetes and heart health significantly. However, it is rarely recommended by doctors due to misconceptions about risk. If you meet the criteria, ask your doctor for a referral to a bariatric specialist.

Conservative management of obesity requires a structured, multidisciplinary lifestyle intervention (energy-reduced diet, increased physical activity, behavioral therapy) targeting a 5-10% weight loss within 6 months to improve comorbidities.

Start with a modest goal: lose 5-10% of your body weight over 6 months. This is achieved by eating 500-600 calories less per day and moving moderately for 150-300 minutes a week. Work with a team including a doctor and dietitian to make this sustainable.

Type 2 diabetes remission is achievable through significant weight loss (specifically targeting ectopic fat in the liver and pancreas) via very low-calorie diets or bariatric surgery, challenging the view that T2D is an irreversible progressive disease.

To put Type 2 Diabetes into remission, you must lose a significant amount of weight (typically >15kg or >15% of body weight) to remove fat from your liver and pancreas. This is best achieved through a medically supervised Very Low-Calorie Diet (500-800 kcal/day) using meal replacements for 3 months, followed by a structured maintenance plan. This approach is most effective if you have had diabetes for less than 6-10 years.

Intensive lifestyle interventions modeled on the Diabetes Prevention Program (DPP), including individualized MNT and physical activity, reduce the incidence of type 2 diabetes by 58% in adults with prediabetes and overweight/obesity.

If you have prediabetes and are overweight, ask your doctor about a DPP-modeled lifestyle program. The goal is to lose 7-10% of your body weight and get 150 minutes of moderate exercise per week. This approach is proven to cut your risk of developing type 2 diabetes by more than half. It is often covered by insurance.

Eliminating sugar-sweetened beverages reduces body weight in adolescents and children.

If you are an adolescent or child, or if you are helping one, stop drinking sugary beverages. This simple change has been shown in large trials to reduce body weight over 1-1.5 years.

Sustained weight loss requires a permanent reduction in energy intake below the body's reduced energy expenditure, as metabolic adaptation lowers energy needs during weight loss.

To keep weight off, you must eat less than you did before you lost the weight, because your body burns fewer calories at a lower weight. This isn't a failure of willpower; it's biology. You need to permanently adjust your intake to match your new, lower energy needs.

Lifestyle interventions (dietary changes and physical activity) are the foundational and preferred first-line treatment for obesity management, although they are difficult for many patients to maintain long-term.

Start with lifestyle changes: adjust your diet to reduce caloric intake and increase physical activity. This is the standard first step for treating obesity. If you find it difficult to maintain these changes, do not view this as a personal failure; the paper notes this is a common challenge. In such cases, consult a healthcare provider about adding pharmacological treatments or metabolic surgery as adjunctive or alternative options tailored to your specific needs.

Obesity is the most significant risk factor for the development and progression of Type 2 Diabetes, with obesity accounting for 44% of diabetes cases globally.

Your weight is the biggest lever you have in preventing or managing Type 2 Diabetes. The data shows that carrying excess weight significantly increases your risk, so maintaining a healthy weight is the single most effective preventive measure available.

Modest weight loss of 5-10% of baseline body weight significantly improves glycemic control (A1C reduction of 0.6-1.0%) and reduces the need for diabetes medications.

Aiming to lose just 5-10% of your current body weight can significantly lower your A1C by up to 1% and may allow you to reduce your diabetes medications. This is a realistic and highly effective initial target for managing diabetes.

Regular physical activity (150-300 min moderate or 75-150 min vigorous aerobic activity plus resistance training 2x/week) protects against age-associated weight gain and targets fat and muscle mass respectively.

Aim for at least 75 minutes of vigorous or 150 minutes of moderate aerobic exercise per week, plus two days of strength training. This combination is crucial for managing menopause-related fat gain and muscle loss.

Ultra-processed diets cause increased energy intake and weight gain compared to unprocessed diets, likely due to modifications in the food matrix affecting satiety and nutrient bioavailability.

Be aware that ultra-processed foods are engineered to bypass normal satiety signals, leading to passive overconsumption. This is not a personal failure but a property of the food. To manage weight, prioritize foods that naturally promote satiety (whole foods) and limit UPF.

Chronic exercise training leads to structural and metabolic adaptations, including mitochondrial biogenesis (via PGC-1a) and muscle hypertrophy (via mTORC), which improve energy efficiency and force generation.

Consistent training changes your body's machinery. Your muscles become better at producing energy (mitochondria) and stronger (hypertrophy). This makes daily activities easier and improves your overall metabolic health over time.

Sustained weight loss of at least 5% is recommended for individuals with overweight or obesity at moderate atherosclerotic cardiovascular disease (ASCVD) risk to reduce cardiometabolic risk factors and delay type 2 diabetes onset.

If you are at moderate cardiovascular risk, aim to lose just 5% of your body weight through a daily calorie deficit of 500-750 calories and 150 minutes of weekly exercise. This modest loss is scientifically proven to significantly lower your blood pressure, improve cholesterol, and drastically reduce your risk of developing type 2 diabetes.

Bariatric surgery (Roux-en-Y or Sleeve Gastrectomy) provides superior long-term weight loss and metabolic remission compared to conservative lifestyle interventions alone.

If you have severe obesity and metabolic syndrome, lifestyle changes alone rarely sustain weight loss long-term. Bariatric surgery (like Sleeve or Gastric Bypass) is the most effective treatment, offering nearly 20% total body weight loss and high rates of diabetes/blood pressure remission that diet alone cannot achieve.

Weight loss interventions, particularly pharmacologic treatments like GLP-1 receptor agonists (e.g., semaglutide, tirzepatide), significantly reduce OSA severity and may reduce cardiovascular disease risk.

If you have sleep apnea and are overweight, losing weight is one of the most powerful things you can do for your heart and your sleep. Modern medications like semaglutide or tirzepatide can help you lose significant weight, which directly reduces the severity of your sleep apnea and your risk of heart disease. Discuss these options with your doctor.

Once-weekly subcutaneous semaglutide (2.4 mg) resulted in a mean body weight change of -16.0% compared to -5.7% for placebo at week 68.

Semaglutide can be an effective adjunct treatment for weight management in adults with overweight or obesity.

A higher percentage of participants treated with semaglutide lost at least 5% of baseline body weight compared to placebo (86.6% vs 47.6%).

Semaglutide significantly increases the likelihood of achieving clinically meaningful weight loss.

Treatment with tirzepatide resulted in a least-squares mean percent change in weight of -20.2% at week 72, compared to -13.7% with semaglutide.

Tirzepatide may be a more effective option for weight loss in obese adults without diabetes.

Tirzepatide led to a least-squares mean change in waist circumference of -18.4 cm, while semaglutide led to -13.0 cm.

Tirzepatide may also be beneficial for reducing waist circumference in obese adults without diabetes.

Participants in the tirzepatide group were more likely to achieve weight reductions of at least 10%, 15%, 20%, and 25% compared to the semaglutide group.

Tirzepatide may provide a higher chance of achieving significant weight loss milestones in obese adults without diabetes.

Tirzepatide at doses of 5 mg, 10 mg, or 15 mg once weekly resulted in a mean percentage change in weight of -15.0%, -19.5%, and -20.9% respectively at week 72.

Tirzepatide is effective for significant weight loss in adults with obesity.

85%, 89%, and 91% of participants achieved a weight reduction of 5% or more with 5 mg, 10 mg, and 15 mg of tirzepatide respectively.

A high percentage of adults with obesity can expect significant weight loss with tirzepatide.

Metabolic and bariatric surgery (MBS) is an effective means of durable weight loss, with sleeve gastrectomy being the most performed procedure, offering significant long-term weight loss and diabetes remission.

If lifestyle changes and medications aren't enough, consider metabolic and bariatric surgery (MBS). It offers the most durable weight loss, especially sleeve gastrectomy and gastric bypass. It's suitable for those with BMI >35 (or >30 with health issues). You must commit to lifelong monitoring and supplementation to prevent nutrient deficiencies.

Retatrutide and dual agonists achieved equivalent mean weight loss of -11.0 kg, surpassing GLP-1RAs which had a mean weight loss of -9.0 kg.

Practitioners can expect retatrutide and dual agonists to provide significant weight loss compared to GLP-1RAs.